Table 2.
Mortality, first contact
| Patients | 7-day mortality | 8–30-day mortality | 31–365-day mortality | 1-year mortality |
| % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
| Organ failure | ||||
| Yes | 11.0 (10.2 to 11.8) | 5.6 (5.1 to 6.2) | 13.2 (12.3 to 14.1) | 29.8 (28.6 to 31.0) |
| No | 1.4 (1.3 to 1.6) | 1.2 (1.1 to 1.3) | 5.2 (5.0 to 5.4) | 7.9 (7.6 8.2) |
| Site of organ failure | ||||
| Respiratory | 7.9 (6.9 to 9.0) | 6.4 (5.6 to 7.4) | 13.5 (12.3 to 14.8) | 27.8 (26.2 to 29.5) |
| Circulatory | 11.0 (9.3 to 12.9) | 5.5 (4.3 to 6.9) | 13.0 (11.2 to 15.1) | 29.6 (27.0 to 32.2) |
| Coagulation | 12.6 (9.1 to 16.8) | 7.1 (4.5 to 10.6) | 13.9 (10.3 to 18.3) | 33.7 (28.4 to 39.2) |
| Hepatic | 6.5 (4.9 to 8.6) | 8.6 (6.6 to 10.8) | 11.8 (9.6 to 14.4) | 26.9 (23.8 to 30.3) |
| Renal | 14.3 (11.9 to 17.0) | 8.4 (6.5 to 10.6) | 18.2 (15.5 to 21.1) | 40.9 (37.4 to 44.5) |
| Cerebral | 33.8 (31.0 to 36.8) | 3.9 (2.8 to 5.3) | 9.3 (7.6 to 11.2) | 47.1 (44.0 to 50.1) |
| Number of organ failures | ||||
| 1 | 9.0 (8.2 to 9.8) | 4.9 (4.3 to 5.5) | 13.2 (12.2 to 14.1) | 27.0 (25.8 to 28.3) |
| 2 | 18.7 (15.9 to 21.7) | 9.2 (7.2 to 11.5) | 13.8 (11.4 to 16.5) | 41.7 (38.1 to 45.3) |
| ≥3 | 36.6 (29.2 to 44.6) | 13.0 (8.3 to 19.2) | 11.2 (6.8 to 17.1) | 60.9 (52.9 to 68.5) |